EUVIMEDEUVIMED entdecken
Crossref

miR-34a-5p, miR-340-3p, CCL22, and CXCL16 in Parkinson’s disease: peripheral expression patterns and transcriptomic insights

Mahya Jannati, Saeid Afshar, Misagh Rajabinejad, Mehrdokht Mazdeh, Elaheh Talebi-Ghane, Mahyar Salmani, Mohammad Mahdi Eftekharian

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-13172-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 19.11.2026. Verfasst von Mahya Jannati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Fahmideh Blvd, Hamadan, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Chemokine CXCL16, Parkinson Disease, Chemokine CCL22. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsChemokine CXCL16Parkinson DiseaseChemokine CCL22HumansFemaleMaleAgedTranscriptomeMiddle AgedGene Expression ProfilingGene Expression RegulationCase-Control Studies

Stichwörter der Autor:innen

miRNANeuroimmunologyNeuroinflammationParkinson''s diseaseTranscriptomics

Substanzen

MicroRNAsChemokine CXCL16CXCL16 protein, humanChemokine CCL22CCL22 protein, humanMIRN34 microRNA, human

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Fahmideh Blvd, Hamadan, Iran.
  • Cancer Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Hamadan, Iran.
  • Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Fahmideh Blvd, Hamadan, Iran. m.rajabinejad@umsha.ac.ir.
  • Cancer Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, Iran. m.rajabinejad@umsha.ac.ir.
  • Department of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Zitieren

APA

Jannati, M., Afshar, S., Rajabinejad, M., Mazdeh, M., Talebi-Ghane, E., Salmani, M., & Eftekharian, M. M. (2026). miR-34a-5p, miR-340-3p, CCL22, and CXCL16 in Parkinson’s disease: peripheral expression patterns and transcriptomic insights. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13172-0

Vancouver

Jannati M, Afshar S, Rajabinejad M, Mazdeh M, Talebi-Ghane E, Salmani M, et al. miR-34a-5p, miR-340-3p, CCL22, and CXCL16 in Parkinson’s disease: peripheral expression patterns and transcriptomic insights. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13172-0

BibTeX
@article{Jannati2026,
  author = {Jannati, Mahya and Afshar, Saeid and Rajabinejad, Misagh and Mazdeh, Mehrdokht and Talebi-Ghane, Elaheh and Salmani, Mahyar and Eftekharian, Mohammad Mahdi},
  title = {miR-34a-5p, miR-340-3p, CCL22, and CXCL16 in Parkinson’s disease: peripheral expression patterns and transcriptomic insights},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-13172-0}
}
Kostenlos starten →